Javascript must be enabled to continue!
Systolic Time Interval Characteristics in Children with Duchenne's Progressive Muscular Dystrophy
View through CrossRef
Systolic time interval (STI) characteristics of 17 boys with Duchenne's muscular dystrophy (DMD) were compared with those of 80 normal boys who served as control subjects. The heart rate decreased linearly with age in normal control subjects (r = -.47, P < .01). By contrast, heart rate was significantly higher in patients with DMD (P <.001) and tended to increase further with age. Each STI variable for normal control subjects increased significantly with age (P ≤ .01); QII, left ventricular ejection time (LVET), and pre-ejection period (PEP), in addition, decreased with increasing heart rate (P ≤ .05). In dystrophic patients QII and LVET decreased with increasing heart rate (P < .001) but were not influenced by age. None of the other STI values in dystrophic patients was significantly influenced by either age or heart rate. Mean QII, LVET, and QI were shorter and PEP, isometric contraction time (ICT), and PEP/LVET ratio were longer (P < .001) for DMD patients than for normal control subjects. In 13/17 patients, QII and LVET were below the 95% confidence interval of the normal mean, whereas PEP, ICT, and PEP/LVET exceeded the upper limits of normal in 8, 9, and 11 patients, respectively. For dystrophic patients, the difference (Δ) between the observed values and those predicted from regression equations for normal control subjects was lower for QII, LVET, and QI (P < .01) but higher for PEP (P < .04), ICT, and PEP/LVET ratio (P < .001). Δ QII and Δ LVET increased with age (P = .001 and .032, respectively). Duchenne's muscular dystrophy is thus documented to be associated with substantial alterations in STI characteristics that suggest a compromise of global left ventricular performance. Some of these abnormalities increase with age, probably reflecting the progressive cardiomyopathy characteristic of this disease.
American Academy of Pediatrics (AAP)
Title: Systolic Time Interval Characteristics in Children with Duchenne's Progressive Muscular Dystrophy
Description:
Systolic time interval (STI) characteristics of 17 boys with Duchenne's muscular dystrophy (DMD) were compared with those of 80 normal boys who served as control subjects.
The heart rate decreased linearly with age in normal control subjects (r = -.
47, P < .
01).
By contrast, heart rate was significantly higher in patients with DMD (P <.
001) and tended to increase further with age.
Each STI variable for normal control subjects increased significantly with age (P ≤ .
01); QII, left ventricular ejection time (LVET), and pre-ejection period (PEP), in addition, decreased with increasing heart rate (P ≤ .
05).
In dystrophic patients QII and LVET decreased with increasing heart rate (P < .
001) but were not influenced by age.
None of the other STI values in dystrophic patients was significantly influenced by either age or heart rate.
Mean QII, LVET, and QI were shorter and PEP, isometric contraction time (ICT), and PEP/LVET ratio were longer (P < .
001) for DMD patients than for normal control subjects.
In 13/17 patients, QII and LVET were below the 95% confidence interval of the normal mean, whereas PEP, ICT, and PEP/LVET exceeded the upper limits of normal in 8, 9, and 11 patients, respectively.
For dystrophic patients, the difference (Δ) between the observed values and those predicted from regression equations for normal control subjects was lower for QII, LVET, and QI (P < .
01) but higher for PEP (P < .
04), ICT, and PEP/LVET ratio (P < .
001).
Δ QII and Δ LVET increased with age (P = .
001 and .
032, respectively).
Duchenne's muscular dystrophy is thus documented to be associated with substantial alterations in STI characteristics that suggest a compromise of global left ventricular performance.
Some of these abnormalities increase with age, probably reflecting the progressive cardiomyopathy characteristic of this disease.
Related Results
Challenges in developing gene therapy against Duchenne muscular dystrophy
Challenges in developing gene therapy against Duchenne muscular dystrophy
Duchenne muscular dystrophy is a progressive X-linked recessive neuromuscular disorder resulting from pathogenic mutations in the DMD gene, which codes dystrophin. It is one of the...
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Abstract
Duchenne Muscular Dystrophy is a rare, X-linked neuromuscular disorder that leads to progressive muscle degeneration, loss of ambulation, and premature m...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Background
Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is ...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Ma...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background:
Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an ...
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease; it occurs due to a mutation in the dystrophin protein gene; as a result, the protein is not synthesized an...
Dystrophie Musculaire de Duchenne: Aspects cliniques, biologiques et évolutifs à propos de cinq cas dans le service de Rhumatologie au CHU du Point G.
Dystrophie Musculaire de Duchenne: Aspects cliniques, biologiques et évolutifs à propos de cinq cas dans le service de Rhumatologie au CHU du Point G.
Résumé
La dystrophie musculaire de Duchenne (DMD) due à la non expression de la dystrophine est liée au chromosome X. Décrite au 19e siècle, est la plus courante dystrophie ...
Duchenne De Boulogne: A Pioneer in Neurology and Medical Photography
Duchenne De Boulogne: A Pioneer in Neurology and Medical Photography
ABSTRACT:Guillaume-Benjamin-Amand Duchenne was born 200 years ago in Boulogne-sur-Mer (Pas-de-Calais, France). He studied medicine in Paris and became a physician in 1831. He pract...

